gastric%20cancer
GASTRIC CANCER
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Follow Up

  • A regular follow-up may allow investigation & treatment of symptoms, psychological support & early detection of recurrence, though there is no evidence that it improves survival outcomes
  • Response to systemic treatments should normally be assessed with interval computed tomography (CT) imaging of chest, abdomen & pelvis
  • In the advanced disease setting, identification of patients for second-line chemotherapy & clinical trials requires regular follow-up to detect symptoms of disease progression before significant clinical deterioration
  • The type of pathological response & histologic tumor regression after neoadjuvant therapy has been shown to be a predictor of survival
  • Follow-up should include a complete history & physical examination every 3-6 months for 1-2 years, every 6-12 months for 3-5 years & annually thereafter
  • Patients who have undergone surgical resection should be monitored & treated as indicated for vitamin B12 & iron deficiency
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
17 Dec 2018
Modifiable lifestyle behaviours, such as diet and exercise, significantly affect the risk of colorectal cancer (CRC), a recent study has shown.
Roshini Claire Anthony, 21 Apr 2016
Twenty-year survival is possible in almost 80 percent of children who had a liver transplant and were given cyclosporine as their primary immunosuppressive regimen, according to a study presented at the annual meeting of the European Association for the Study of the Liver (EASL) International Liver Congress™ (ILC) 2016 in Barcelona, Spain.
Pearl Toh, 6 days ago
Adding a proton-pump inhibitor (PPI) to anticoagulant therapy significantly lowers the risk of hospitalizations for upper gastrointestinal (GI) tract bleeding associated with anticoagulant use, a study finds.
5 days ago
Among patients with inflammatory bowel disease (IBD), older age at the time of IBD diagnosis and longer disease duration are associated with a heightened risk of developing colitis-associated neoplasia, a study has found.